Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Non Operating Income (2019 - 2025)

INVO Fertility has reported Non Operating Income over the past 12 years, most recently at -$1.0 million for Q3 2025.

  • Quarterly Non Operating Income fell 235.26% to -$1.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$1.7 million through Sep 2025, down 40.0% year-over-year, with the annual reading at -$993255.0 for FY2024, 19.88% up from the prior year.
  • Non Operating Income was -$1.0 million for Q3 2025 at INVO Fertility, down from -$219006.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $69398.0 in Q2 2021 and troughed at -$1.0 million in Q3 2025.
  • The 5-year median for Non Operating Income is -$219006.0 (2025), against an average of -$286950.4.
  • The largest YoY upside for Non Operating Income was 126.7% in 2021 against a maximum downside of 1766.77% in 2021.
  • A 5-year view of Non Operating Income shows it stood at -$401773.0 in 2021, then surged by 88.39% to -$46659.0 in 2022, then crashed by 892.9% to -$463279.0 in 2023, then surged by 53.95% to -$213357.0 in 2024, then plummeted by 372.98% to -$1.0 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Non Operating Income are -$1.0 million (Q3 2025), -$219006.0 (Q2 2025), and -$296174.0 (Q1 2025).